Active ingredient
Nedosiran
3 finished FDA listings contain Nedosiran as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- NEDOSIRAN SODIUM
- Dosage forms
- Injection, Solution
- Routes
- Subcutaneous
- Manufacturers / labelers
- 1
- Strengths listed
- 128 mg/.8ml · 160 mg/ml · 80 mg/.5ml
- Brand names in FDA listings
- Rivfloza
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 2675287
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 215842 | NOVO | 2023-09-29 | 3 |
Official labeling on DailyMed
- RIVFLOZA (NEDOSIRAN) INJECTION, SOLUTION [NOVO NORDISK] · version 4 · 2025-04-10
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.